Introduction: Due to an upsurge in antibiotic-resistant infections and lack of therapeutic options, new approaches are needed for treatment.
Introduction
Antibiotic-resistant pathogens (Methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Klebsiella pneumoniae, Clostridium difficile and Enterococcus faecalis) are major causes of severe infections in hospitalized patients leading to longer hospital stays and higher mortality rates worldwide [1, 2] . In the United
States, infections associated with antibiotic-resistant organisms occur in over 2 million people and at least 23,000 deaths are recorded annually [3] . According to the WHO report [2] , people infected with MRSA are reported to be 64% more likely to die than those infected with antibiotic sensitive strains.
Treatment of antibiotic-resistant associated infection is challenging
particularly in healthcare settings due to the increasing trend of antibiotic resistance, side effects of important antibiotics, limited antibiotic options [1, 2] and reduction in new antibiotic discovery endeavors by pharmaceutical companies [2, 4] . Alternative therapeutic interventions that are effective and without adverse effects are urgently needed. Honey is one such promising option.
Natural honey is obtained from nectar collected by honeybees. Its high sugar content coupled with low pH, bee-derived enzymes, beederived peptides and phytochemical compounds contribute to its antibacterial action [5] [6] [7] [8] [9] [10] [11] . Honey also has antioxidant, antiinflammatory and anti-hyaluronidase properties which vary depending on the nectar source [5, 12, 13] . The amount of natural phenol in honey plays a significant role in its inhibition activity [12, 13] . Honeys with high concentration of phenol are more likely to possess high inhibitory efficacy than those with low or no phenol.
The use of honey as medicinal remedy was initiated many centuries ago, but recent publications have demonstrated the antibacterial efficacy of honey in in vitro and in vivo [14] [15] [16] [17] [18] [19] [20] [21] [22] . The antibacterial mechanism of honey has gradually been unraveled [23] . Evidence from published studies show that honey disrupts cell walls in P.
aeruginosa [23] and interrupts cell division in MRSA [24] . Honey also stimulates inflammatory cytokines [25] and has been identified to be a strong scavenger of super peroxide anions and highly effective inhibitor of reactive oxygen species (ROS) stimulated from human polymorphonuclear neutrophils (PMNs) [5] . Both medical grade honey and raw honey have been shown to have broad spectrum antibacterial activity against a plethora of pathogens, including antibiotic-resistant organisms and their biofilms [19, 26, 27] . Furthermore, honey has been shown to heal recalcitrant wounds [28] [29] [30] [31] . Effective application of honey promotes wound healing, prevents cross-infection, and repairs tissue [32] . Unlike some antimicrobial agents (such as fluoroquinolones and clindamycin), honey has no record of adverse side effect on tissues [32] or gut [21] .
Public interest in the therapeutic use of natural honey in recent times has greatly increased [31] . Licensed medical grade honeys are available in the medical field globally but the majority are derived from Leptospermum species found in Australia and New Zealand.
The antibacterial property of medical grade Manuka honey is highly recognized in the research field due to its high unique property, Unique Manuka factor (UMF). Though much work has been done on honey, little is known about the antibacterial efficacy of honey from the United States. In this pilot study, our goals were to compare the efficacies of American honeys and artificial honey on antibioticresistant pathogens and then determined if the antibacterial effect of each honey against these pathogensis primarily due to its high sugar content. and further diluted in SBB to approximately 5x10 6 CFU/ml before further susceptibility tests were performed. Colony count was also monitored on BA plates to ensure all the wells received equal and accurate amount of inoculum density.
Methods

Types of honey
Minimum inhibitory concentration determination
The minimum inhibitory concentration (MIC) was determined in 96 well round-bottomed microtiter plates (Corning Incorporated, New
York, USA). Broth microdilution method was used according to CLSI guidelines [34] and [35] with modifications. A volume of 100 µl of varied honey concentrations (0-50%) (w/v) was distributed in wells 1-10. Wells 11 and 12 were considered positive (broth) and negative controls (broth and honey only), respectively.
Subsequently, wells 1-11 were seeded with an aliquot of 10 µl of approximately 10 6 CFU/mL of overnight MHB culture and incubated at 37°C for 24 h aerobically. Positive control and negative control were added to monitor viability and sterility of honey, respectively.
Reference stains were also included to monitor consistency. Wells with the lowest honey concentrations which prevented growth/turbidity under a magnifying mirror were considered as MIC.
For quality assurance purposes, each experiment was run in triplicate at different occasions. The method was validated by using standard antibiotics against the reference strains and the results compared to that in CLSI literature.
Minimum bactericidal concentration determination
Minimum bactericidal concentration (MBC) was determined by plating 10 µl of content from all the MIC wells without visible growth/turbidity onto antibiotic-free or honey-free BA plates in duplicate and incubating aerobically and anaerobically as required.
Positive and negative control wells were included. The lowest honey concentration that killed the organism was considered the MBC.
MBCs were determined on three separate occasions.
Statistical analysis
Data was entered into Microsoft Excel® 2010 and analyzed. The Student´s t-test was performed to determine whether the differences in mean of Wisconsin Buckwheat honey (WBH) and the AH for each isolate were significant. A p-value ≤ 0.05 was considered significant. For each honey type, the ratio of MBC to MIC was determined and used to classify the antibacterial activity of the honey as either bactericidal or bacteriostatic. Bactericidal was defined as MBC/MIC ratio less than or equal to 4, while a MBC/MIC ratio above 4 and less than 16 was considered bacteriostatic [36] .
Page number not for citation purposes 4
Results
The selected pathogens for the study are listed in Table 1 
Discussion
The rise in multidrug and extreme antibiotic-resistant pathogens in the healthcare settings is so alarming that it has become necessary to find alternative and effective natural therapeutic agents. In this study, we tested the potency of four local honeys against standardized pathogens (MRSA, P. aeruginosa, MSSA, VRE, E.
faecalis, K. pneumoniae and C. difficile). Honeys that did not exhibit bactericidal activity at 50% (w/v) during the study were excluded.
Our study demonstrated that MICs of WBH for the four C. [15, 16, 19, 22, 33, 37, 39] .
To investigate the role of high sugar content of selected honeys on antibacterial activity, we exposed test pathogens to various concentrations of AH (10-50% w/v) to mimic the main sugar composition in natural honeys. Our findings indicated that a high AH concentration (50% w/v) failed to completely prevent any of the pathogens from growth, whereas WBH exhibited bactericidal activity at very low honey concentrations (6.25% w/v). A similar conclusion was reported by [16] . Likewise at 50% (w/v), cranberry honey, wild honey and orange blossom honey supported the growth of all the studied pathogens. This further confirms that bactericidal activity of honey is not solely due to the presence of high sugar content and that varying potent antibacterial compounds in honey may work synergistically to extensively disrupt cells and lysis of pathogens as reported by Henriques et al. [23] . This study suggests that WBH may have a complex composition that could effectively resist multiple antibiotic-resistant pathogens to thrive.
WBH remarkably displayed broad spectrum antimicrobial activity in this study. Other published research have demonstrated that phenolic compound in buckwheat honey is high and this influences its antibacterial property [5, 12, 13] . Based on this, we can deduce that the phenol content in Wisconsin honey may be high, and hence could be a major factor contributing to its antibacterial activity against these important hospital acquired pathogens. 
Conclusion
We provide the first data on antibacterial efficacy of buckwheat honey from Wisconsin, USA against nosocomial or hospital acquired
pathogens. Our data demonstrate that antibiotic and multiple drug resistant pathogen(s) were susceptible to WBH. We also deduced that the antibacterial effect of WBH on pathogens including C. 
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